{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T03:38:10Z","timestamp":1752550690155},"reference-count":42,"publisher":"Japan Atherosclerosis Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2024,8,1]]},"DOI":"10.5551\/jat.64600","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T22:14:00Z","timestamp":1709158440000},"page":"1194-1214","source":"Crossref","is-referenced-by-count":4,"title":["The Risk of Coronary Artery Calcification according to Different Lipid Parameters and Average Lipid Parameters"],"prefix":"10.5551","volume":"31","author":[{"given":"Tae Kyung","family":"Yoo","sequence":"first","affiliation":[{"name":"Department of Medicine, MetroWest Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi Yeon","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Department of R&amp;D Management, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki-Chul","family":"Sung","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Greenland P, Blaha MJ, Budoff MJ, Erbel R and Watson KE: Coronary Calcium Score and Cardiovascular Risk. J Am Coll Cardiol, 2018; 72: 434-447","DOI":"10.1016\/j.jacc.2018.05.027"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Osawa K, Nakanishi R and Budoff M: Coronary Artery Calcification. Glob Heart, 2016; 11: 287-293","DOI":"10.1016\/j.gheart.2016.08.001"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Bor\u00e9n J, Chapman MJ, Krauss RM, Packard CJ, Bentzon JF, Binder CJ, Daemen MJ, Demer LL, Hegele RA, Nicholls SJ, Nordestgaard BG, Watts GF, Bruckert E, Fazio S, Ference BA, Graham I, Horton JD, Landmesser U, Laufs U, Masana L, Pasterkamp G, Raal FJ, Ray KK, Schunkert H, Taskinen M-R, van de Sluis B, Wiklund O, Tokgozoglu L, Catapano AL and Ginsberg HN: Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. European Heart Journal, 2020; 41: 2313-2330","DOI":"10.1093\/eurheartj\/ehz962"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Wilkins JT, Li RC, Sniderman A, Chan C and Lloyd-Jones DM: Discordance Between Apolipoprotein B and LDL-Cholesterol in Young Adults Predicts Coronary Artery Calcification. Journal of the American College of Cardiology, 2016; 67: 193-201","DOI":"10.1016\/j.jacc.2015.10.055"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Seo HA, Choi YK, Jeon JH, Lee JE, Jeong JY, Moon SS, Lee IK, Kim BW and Kim JG: The Relationship Between Coronary Artery Calcification and Serum Apolipoprotein A-1 in Patients with Type 2 Diabetes. kdj, 2009; 33: 485-493","DOI":"10.4093\/kdj.2009.33.6.485"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Zalawadiya SK, Veeranna V, Panaich S, Kottam A and Afonso L: Non-High-Density Lipoprotein Cholesterol and Coronary Artery Calcium Progression in a Multiethnic US Population. The American Journal of Cardiology, 2014; 113: 471-474","DOI":"10.1016\/j.amjcard.2013.10.027"},{"key":"7","unstructured":"7) Neglia D, Aimo A, Caselli C and Gimelli A: The triglyceride HDL cholesterol ratio: an independent predictor of obstructive coronary artery disease and myocardial ischemia in patients with chronic coronary syndrome. Journal of Nuclear Medicine, 2021; 62: 1671-1671"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Aimo A, Chiappino S, Clemente A, Della Latta D, Martini N, Georgiopoulos G, Panichella G, Piagneri V, Storti S, Monteleone A, Passino C, Chiappino D, Emdin M, Gimelli A and Neglia D: The triglyceride\/HDL cholesterol ratio and TyG index predict coronary atherosclerosis and outcome in the general population. European Journal of Preventive Cardiology, 2021; 29: e203-e204","DOI":"10.1093\/eurjpc\/zwab164"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Quispe R, Elshazly MB, Zhao D, Toth PP, Puri R, Virani SS, Blumenthal RS, Martin SS, Jones SR and Michos ED: Total cholesterol\/HDL-cholesterol ratio discordance with LDL-cholesterol and non-HDL-cholesterol and incidence of atherosclerotic cardiovascular disease in primary prevention: The ARIC study. Eur J Prev Cardiol, 2020; 27: 1597-1605","DOI":"10.1177\/2047487319862401"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Liu X, Wang Y, Wu J, Wang A, Zhang X, Cao Z and Zhao X: Association Between Cumulative Exposure to Increased Low-Density Lipoprotein Cholesterol and the New Occurrence of Peripheral Artery Disease. Frontiers in Neurology, 2021; 12:","DOI":"10.3389\/fneur.2021.696695"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Hao Q-Y, Gao J-W, Yuan Z-M, Gao M, Wang J-F, Schiele F, Zhang S-L and Liu P-M: Remnant Cholesterol and the Risk of Coronary Artery Calcium Progression: Insights From the CARDIA and MESA Study. Circulation: Cardiovascular Imaging, 2022; 15: e014116","DOI":"10.1161\/CIRCIMAGING.122.014116"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Bruemmer D and Cho L: Remnant Cholesterol. Circulation: Cardiovascular Imaging, 2021; 14: e012615","DOI":"10.1161\/CIRCIMAGING.121.012615"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Jepsen A-MK, Langsted A, Varbo A, Bang LE, Kamstrup PR and Nordestgaard BG: Increased Remnant Cholesterol Explains Part of Residual Risk of All-Cause Mortality in 5414 Patients with Ischemic Heart Disease. Clinical Chemistry, 2016; 62: 593-604","DOI":"10.1373\/clinchem.2015.253757"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Tintut Y, Hsu JJ and Demer LL: Lipoproteins in Cardiovascular Calcification: Potential Targets and Challenges. Front Cardiovasc Med, 2018; 5: 172","DOI":"10.3389\/fcvm.2018.00172"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Yoo TK, Lee MY, Lee SA, Cheong ES, Seo MH and Sung KC: Association of Glycosylated Hemoglobin Level and Cancer-Related Mortality in Patients without Diabetes. Journal of Clinical Medicine, 2022; 11: 5933","DOI":"10.3390\/jcm11195933"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Sung KC, Yoo TK, Lee MY, Byrne CD, Zheng MH and Targher G: Comparative Associations of Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Fatty Liver Disease With Coronary Artery Calcification: A Cross-Sectional and Longitudinal Cohort Study. Arterioscler Thromb Vasc Biol, 2023; 43: 482-491","DOI":"10.1161\/ATVBAHA.122.318661"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Varbo A and Nordestgaard BG: Directly measured vs. calculated remnant cholesterol identifies additional overlooked individuals in the general population at higher risk of myocardial infarction. Eur Heart J, 2021; 42: 4833-4843","DOI":"10.1093\/eurheartj\/ehab293"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Tastet L, Capoulade R, Shen M, Clavel MA, C\u00f4t\u00e9 N, Mathieu P, Arsenault M, B\u00e9dard \u00c9, Tremblay A, Samson M, Boss\u00e9 Y, Dumesnil JG, Arsenault BJ, Beaudoin J, Bernier M, Despr\u00e9s JP and Pibarot P: ApoB\/ApoA\u2010I Ratio is Associated With Faster Hemodynamic Progression of Aortic Stenosis: Results From the PROGRESSA (Metabolic Determinants of the Progression of Aortic Stenosis) Study. Journal of the American Heart Association, 2018; 7: e007980","DOI":"10.1161\/JAHA.117.007980"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Brunner FJ, Waldeyer C, Ojeda F, Salomaa V, Kee F, Sans S, Thorand B, Giampaoli S, Brambilla P, Tunstall-Pedoe H, Moitry M, Iacoviello L, Veronesi G, Grassi G, Mathiesen EB, S\u00f6derberg S, Linneberg A, Brenner H, Amouyel P, Ferri\u00e8res J, Tamosiunas A, Nikitin YP, Drygas W, Melander O, J\u00f6ckel KH, Leistner DM, Shaw JE, Panagiotakos DB, Simons LA, Kavousi M, Vasan RS, Dullaart RPF, Wannamethee SG, Ris\u00e9rus U, Shea S, de Lemos JA, Omland T, Kuulasmaa K, Landmesser U and Blankenberg S: Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium. Lancet, 2019; 394: 2173-2183","DOI":"10.1016\/S0140-6736(19)32519-X"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Krishnaveni P and Gowda VM: Assessing the Validity of Friedewald\u2019s Formula and Anandraja\u2019s Formula For Serum LDL-Cholesterol Calculation. J Clin Diagn Res, 2015; 9: Bc01-04","DOI":"10.7860\/JCDR\/2015\/16850.6870"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Casta\u00f1er O, Pint\u00f3 X, Subirana I, Amor AJ, Ros E, Hern\u00e1ez \u00c1, Mart\u00ednez-Gonz\u00e1lez M\u00c1, Corella D, Salas-Salvad\u00f3 J, Estruch R, Lapetra J, G\u00f3mez-Gracia E, Alonso-Gomez AM, Fiol M, Serra-Majem L, Corbella E, Benaiges D, Sorli JV, Ruiz-Canela M, Babi\u00f3 N, Sierra LT, Ortega E and Fit\u00f3 M: Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease. Journal of the American College of Cardiology, 2020; 76: 2712-2724","DOI":"10.1016\/j.jacc.2020.10.008"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Sung KC, Hong YS, Lee JY, Lee SJ, Chang Y, Ryu S, Zhao D, Cho J, Guallar E and Lima JAC: Physical activity and the progression of coronary artery calcification. Heart, 2021; 107: 1710-1716","DOI":"10.1136\/heartjnl-2021-319346"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Jr. and Detrano R: Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol, 1990; 15: 827-832","DOI":"10.1016\/0735-1097(90)90282-T"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Varbo A and Nordestgaard BG: Directly measured vs. calculated remnant cholesterol identifies additional overlooked individuals in the general population at higher risk of myocardial infarction. European Heart Journal, 2021; 42: 4833-4843","DOI":"10.1093\/eurheartj\/ehab293"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Xie G, Zhong Y, Yang S and Zou Y: Remnant Cholesterol is an Independent Predictor of New-Onset Diabetes: A Single-Center Cohort Study. Diabetes Metab Syndr Obes, 2021; 14: 4735-4745","DOI":"10.2147\/DMSO.S341285"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Faridi KF, Quispe R, Martin SS, Hendrani AD, Joshi PH, Brinton EA, Cruz DE, Banach M, Toth PP, Kulkarni K and Jones SR: Comparing different assessments of remnant lipoprotein cholesterol: The very large database of lipids. J Clin Lipidol, 2019; 13: 634-644","DOI":"10.1016\/j.jacl.2019.06.001"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Chen J, Kuang J, Tang X, Mao L, Guo X, Luo Q, Peng D and Yu B: Comparison of calculated remnant lipoprotein cholesterol levels with levels directly measured by nuclear magnetic resonance. Lipids Health Dis, 2020; 19: 132","DOI":"10.1186\/s12944-020-01311-w"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Huh JH, Han K-d, Cho YK, Roh E, Kang JG, Lee SJ and Ihm S-H: Remnant cholesterol and the risk of cardiovascular disease in type 2 diabetes: a nationwide longitudinal cohort study. Cardiovascular Diabetology, 2022; 21: 228","DOI":"10.1186\/s12933-022-01667-6"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Quispe R, Martin SS, Michos ED, Lamba I, Blumenthal RS, Saeed A, Lima J, Puri R, Nomura S, Tsai M, Wilkins J, Ballantyne CM, Nicholls S, Jones SR and Elshazly MB: Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study. European Heart Journal, 2021; 42: 4324-4332","DOI":"10.1093\/eurheartj\/ehab432"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Reyes-Soffer G, Ginsberg HN, Berglund L, Duell PB, Heffron SP, Kamstrup PR, Lloyd-Jones DM, Marcovina SM, Yeang C and Koschinsky ML: Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology, 2022; 42: e48-e60","DOI":"10.1161\/ATV.0000000000000147"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Mora S, Otvos JD, Rifai N, Rosenson RS, Buring JE and Ridker PM: Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation, 2009; 119: 931-939","DOI":"10.1161\/CIRCULATIONAHA.108.816181"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Glavinovic T, Thanassoulis G, Graaf Jd, Couture P, Hegele RA and Sniderman AD: Physiological Bases for the Superiority of Apolipoprotein B Over Low&amp;#x2010; Density Lipoprotein Cholesterol and Non&amp;#x2013; High&amp;#x2010; Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk. Journal of the American Heart Association, 2022; 11: e025858","DOI":"10.1161\/JAHA.122.025858"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Sung KC, Kwon CH, Lee MY, Kwon MJ, Lee JH, Jung MH and Shin JH: Comparison of Low-Density Lipoprotein Cholesterol Concentrations by Direct Measurement and by Friedewald Calculation. Am J Cardiol, 2020; 125: 866-873","DOI":"10.1016\/j.amjcard.2019.12.036"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, Ferranti Sd, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC, Sperling L, Virani SS and Yeboah J: 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 2019; 139: e1082-e1143","DOI":"10.1161\/CIR.0000000000000624"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Nauck M, Warnick GR and Rifai N: Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation. Clin Chem, 2002; 48: 236-254","DOI":"10.1093\/clinchem\/48.2.236"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Sajja A, Park J, Sathiyakumar V, Varghese B, Pallazola VA, Marvel FA, Kulkarni K, Muthukumar A, Joshi PH, Gianos E, Hirsh B, Mintz G, Goldberg A, Morris PB, Sharma G, Blumenthal RS, Michos ED, Post WS, Elshazly MB, Jones SR and Martin SS: Comparison of Methods to Estimate Low-Density Lipoprotein Cholesterol in Patients With High Triglyceride Levels. JAMA Network Open, 2021; 4: e2128817-e2128817","DOI":"10.1001\/jamanetworkopen.2021.28817"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Wongcharoen W, Sutthiwutthichai S, Gunaparn S and Phrommintikul A: Is non-HDL-cholesterol a better predictor of long-term outcome in patients after acute myocardial infarction compared to LDL-cholesterol? : a retrospective study. BMC Cardiovascular Disorders, 2017; 17: 10","DOI":"10.1186\/s12872-016-0450-9"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Behbodikhah J, Ahmed S, Elyasi A, Kasselman LJ, De Leon J, Glass AD and Reiss AB: Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target. Metabolites, 2021; 11:","DOI":"10.3390\/metabo11100690"},{"key":"39","unstructured":"39) Hajian-Tilaki K, Heidari B and Bakhtiari A: Triglyceride to high-density lipoprotein cholesterol and low-density lipoprotein cholestrol to high-density lipoprotein cholesterol ratios are predictors of cardiovascular risk in Iranian adults: Evidence from a population-based cross-sectional study. Caspian J Intern Med, 2020; 11: 53-61"},{"key":"40","unstructured":"40) Mill\u00e1n J, Pint\u00f3 X, Mu\u00f1oz A, Z\u00fa\u00f1iga M, Rubi\u00e9s-Prat J, Pallardo LF, Masana L, Mangas A, Hern\u00e1ndez-Mijares A, Gonz\u00e1lez-Santos P, Ascaso JF and Pedro-Botet J: Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention. Vasc Health Risk Manag, 2009; 5: 757-765"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Proctor SD, Vine DF and Mamo JC: Arterial retention of apolipoprotein B(48)- and B(100)-containing lipoproteins in atherogenesis. Curr Opin Lipidol, 2002; 13: 461-470","DOI":"10.1097\/00041433-200210000-00001"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Hsu HY, Tsai MC, Yeh TL, Hsu LY, Hwang LC and Chien KL: Association of baseline as well as change in lipid levels with the risk of cardiovascular diseases and all-cause deaths. Sci Rep, 2021; 11: 7381","DOI":"10.1038\/s41598-021-86336-6"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/31\/8\/31_64600\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T04:34:33Z","timestamp":1722659673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/31\/8\/31_64600\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.64600","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"type":"print","value":"1340-3478"},{"type":"electronic","value":"1880-3873"}],"subject":[],"published":{"date-parts":[[2024,8,1]]},"article-number":"64600"}}